Related Experiment Videos

Cognitive functioning in 8- to 18-month-old drug-exposed infants

S M Alessandri1, M Bendersky, M Lewis

  • 1Department of Child and Adolescent Psychiatry, Medical College of Pennsylvania, USA.

Insights

Infants with heavy prenatal cocaine exposure showed no cognitive differences at 8 months but experienced a decline in mental development by 18 months, even when controlling for other risks.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pediatrics

Background:

  • Prenatal exposure to substances like cocaine can impact infant development.
  • Cognitive functioning is a critical area of development in early childhood.
  • Understanding long-term effects requires longitudinal studies controlling for confounding factors.

Purpose of the Study:

  • To examine the cognitive functioning of infants with varying levels of prenatal cocaine exposure.
  • To assess the impact of cocaine exposure on infant development at 8 and 18 months.
  • To investigate the relationship between prenatal cocaine exposure, environmental risk, and cognitive outcomes.

Main Methods:

  • Cognitive functioning was assessed using the Bayley Scales of Infant Development.
  • Infant information processing was evaluated via an infant-controlled habituation procedure.
  • A cohort of 236 infants (8 months and 18 months) with varying prenatal cocaine exposure levels was studied.

Main Results:

  • Infants exposed to cocaine prenatally had higher neonatal medical and environmental risk scores.
  • At 8 months, no significant differences in cognitive scores (MDI, PDI) were observed between exposure groups.
  • Heavy prenatal cocaine exposure or high environmental risk correlated with a decrease in Mental Development Index (MDI) scores from 8 to 18 months.

Conclusions:

  • Prenatal cocaine exposure alone did not impair cognitive development at 8 months.
  • A decline in cognitive function is evident by 18 months in infants with heavy prenatal cocaine exposure or high environmental risk.
  • These findings highlight the importance of controlling for medical, environmental, and polydrug risks in developmental studies.

Related Concept Videos